Pharma Giant Pfizer recalls blood pressure medicines, brand name as Accuretic from the US market over presence of cancer causing impurities. Accuretic is a combination of quinapril HCl and hydrochlorothiazide.
Pfizer is voluntarily recalling Accuretic tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone to the patient level due to the presence of a nitrosamine, N-nitroso-quinapril, above the acceptable daily intake (ADI) level. Pfizer will recall six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets and four lots of quinapril HCl/ hydrochlorothiazide tablets.
Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables. Everyone is exposed to some level of nitrosamines. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.
Earlier this month, Pfizer completed two recalls in Canada for two of its blood pressure medicines. Now the company is pulling three of its blood pressure drugs off shelves in the United States because of the presence of cancer-causing agents.
The company said it has not received any reports of adverse events linked to any of the treatments and there is no immediate risk to patients taking the medication. Pfizer however advised patients who are taking the meds to consult their doctor about alternative treatment options.
Pfizer is recalling six lots of Accuretic that it provided to distributors in the U.S. and Puerto Rico between November 2019 and this month. Earlier this month, the company pulled eight lots of Accuretic in Canada.
Subscribe to PharmaTutor News Alerts by Email
